<VariationArchive VariationID="213214" VariationName="NM_001114753.3(ENG):c.1080_1083del (p.Thr361fs)" VariationType="Deletion" Accession="VCV000213214" Version="21" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-05-01" DateCreated="2016-10-09" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="209952" VariationID="213214">
      <GeneList>
        <Gene Symbol="ENG" FullName="endoglin" GeneID="2022" HGNC_ID="HGNC:3349" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127815016" stop="127854658" display_start="127815016" display_stop="127854658" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130577290" stop="130617046" display_start="130577290" display_stop="130617046" Strand="-" />
          </Location>
          <OMIM>131195</OMIM>
          <Haploinsufficiency last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2024-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ENG">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001114753.3(ENG):c.1080_1083del (p.Thr361fs)</Name>
      <CanonicalSPDI>NC_000009.12:127824354:TGTCTG:TG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="127824355" stop="127824358" display_start="127824355" display_stop="127824358" variantLength="4" positionVCF="127824354" referenceAlleleVCF="TTGTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="130586634" stop="130586637" display_start="130586634" display_stop="130586637" variantLength="4" positionVCF="130586633" referenceAlleleVCF="TTGTC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>T361fs</ProteinChange>
      <ProteinChange>T179fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.2" sequenceAccession="NM_001114753" sequenceVersion="2" change="c.1080_1083delGACA">
            <Expression>NM_001114753.2:c.1080_1083delGACA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.3" sequenceAccession="NM_000118" sequenceVersion="3" change="c.1080_1083delGACA">
            <Expression>NM_000118.3:c.1080_1083delGACA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.130586636_130586639del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.130586636_130586639del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.127824357_127824360del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.127824357_127824360del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009551.1" sequenceAccession="NG_009551" sequenceVersion="1" change="g.35411_35414del">
            <Expression>NG_009551.1:g.35411_35414del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000118.4" sequenceAccession="NM_000118" sequenceVersion="4" change="c.1078_1081delCAGA">
            <Expression>NM_000118.4:c.1078_1081delCAGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000109.1" sequenceAccession="NP_000109" sequenceVersion="1" change="p.Thr361Serfs">
            <Expression>NP_000109.1:p.Thr361Serfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114753.3" sequenceAccession="NM_001114753" sequenceVersion="3" change="c.1080_1083del" MANESelect="true">
            <Expression>NM_001114753.3:c.1080_1083del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108225.1" sequenceAccession="NP_001108225" sequenceVersion="1" change="p.Thr361fs">
            <Expression>NP_001108225.1:p.Thr361fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001278138.2" sequenceAccession="NM_001278138" sequenceVersion="2" change="c.534_537del">
            <Expression>NM_001278138.2:c.534_537del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001265067.1" sequenceAccession="NP_001265067" sequenceVersion="1" change="p.Thr179fs">
            <Expression>NP_001265067.1:p.Thr179fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406715.1" sequenceAccession="NM_001406715" sequenceVersion="1" change="c.1078_1081delCAGA">
            <Expression>NM_001406715.1:c.1078_1081delCAGA</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393644.1" sequenceAccession="NP_001393644" sequenceVersion="1" change="p.Thr361Serfs">
            <Expression>NP_001393644.1:p.Thr361Serfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_589" sequenceAccession="LRG_589">
            <Expression>LRG_589:g.35411_35414del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t1" sequenceAccession="LRG_589t1">
            <Expression>LRG_589t1:c.1080_1083del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p1" sequenceAccession="LRG_589p1" change="p.Thr361fs">
            <Expression>LRG_589p1:p.Thr361fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_589t2" sequenceAccession="LRG_589t2">
            <Expression>LRG_589t2:c.1078_1081del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_589p2" sequenceAccession="LRG_589p2" change="p.Thr361Serfs">
            <Expression>LRG_589p2:p.Thr361Serfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA324999" DB="ClinGen" />
        <XRef Type="rs" ID="863223540" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001114753.3(ENG):c.1080_1083del (p.Thr361fs) AND not provided" Accession="RCV000200429" Version="10">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2020-06-24" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.1080_1083del (p.Thr361fs) AND Telangiectasia, hereditary hemorrhagic, type 1" Accession="RCV000234034" Version="12">
        <ClassifiedConditionList TraitSetID="7437">
          <ClassifiedCondition DB="MedGen" ID="C4551861">Telangiectasia, hereditary hemorrhagic, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-26" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.1080_1083del (p.Thr361fs) AND Hereditary hemorrhagic telangiectasia" Accession="RCV002229104" Version="5">
        <ClassifiedConditionList TraitSetID="43931">
          <ClassifiedCondition DB="MedGen" ID="C0039445">Hereditary hemorrhagic telangiectasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001114753.3(ENG):c.1080_1083del (p.Thr361fs) AND Cardiovascular phenotype" Accession="RCV002415836" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-26" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2016-10-09" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15712270</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15879500</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16542389</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16752392</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17786384</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21158752</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21415079</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22991266</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31630786</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32573726</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9554745</ID>
        </Citation>
        <DescriptionHistory Dated="2024-04-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7437" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16695" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Telangiectasia, hereditary hemorrhagic, type 1</ElementValue>
                <XRef ID="MONDO:0008535" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT1</ElementValue>
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ORW1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary Hemorrhagic Telangiectasia</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000227625" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509787" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558916" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553700" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515716" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506221" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528531" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506222" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500544" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506220" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562015" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511259" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505110" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500545" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528884" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509788" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.</Attribute>
                <XRef ID="NBK1351" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301525</ID>
                <ID Source="BookShelf">NBK1351</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2011">
                <ID Source="PubMed">19553198</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Shovlin et al., 2000">
                <ID Source="PubMed">10751092</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="HHT Foundation Int'l, 2020">
                <ID Source="PubMed">32894695</ID>
              </Citation>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C4551861" DB="MedGen" />
              <XRef ID="MONDO:0008535" DB="MONDO" />
              <XRef Type="MIM" ID="187300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43931" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="40362" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Osler hemorrhagic telangiectasia syndrome</ElementValue>
                <XRef ID="Osler+hemorrhagic+telangiectasia+syndrome/9046" DB="Genetic Alliance" />
                <XRef ID="21877004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary hemorrhagic telangiectasia</ElementValue>
                <XRef ID="MONDO:0019180" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler Weber Rendu syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ORW disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osler-Rendu-Weber disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHT</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="187300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000500010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515719" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6626" />
                <XRef ID="6626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="774" DB="Orphanet" />
              <XRef ID="C0039445" DB="MedGen" />
              <XRef ID="MONDO:0019180" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS187300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="465174" SubmissionDate="2019-01-29" DateLastUpdated="2019-04-17" DateCreated="2015-10-11">
        <ClinVarSubmissionID localKey="GDX:379737|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000250087" DateUpdated="2019-04-17" DateCreated="2015-10-11" Type="SCV" Version="12" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1080_1083delGACA pathogenic variant in the ENG gene, also reported as c.1078_1081delGACA due to alternate nomenclature, has been identified previously in multiple members of a large family with HHT (Gallione et al., 1998). It has also been identified in several other unrelated individuals with HHT (Wehner et al., 2006; Bossler wt al., 2006; Olivieri et al., 2007; Nishida et al., 2012). Additionally, the c.1080_1083delGACA variant has not been observed in large population cohorts (Lek et al., 2016). The c.1080_1083delGACA variant causes a shift in reading frame starting at codon threonine 361, changing it to a serine, and creating a premature stop codon at position 7 of the new reading frame, denoted p.Thr361SerfsX7. This pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Furthermore, other frameshift variants in the ENG gene have been reported in Human Gene Mutation Database in association with HHT (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000118.2:c.1080_1083delGACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2842588" SubmissionDate="2020-05-21" DateLastUpdated="2020-10-30" DateCreated="2020-10-30">
        <ClinVarSubmissionID localKey="ENST00000373203 c.1080_1083delGACA|OMIM:187300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001439428" DateUpdated="2020-10-30" DateCreated="2020-10-30" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32573726</ID>
          </Citation>
          <Comment>PVS1+PM2+PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next-gen sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000118.3:c.1080_1083delGACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="187300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics_HHT</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3373940" SubmissionDate="2021-05-26" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_001114753.2:c.1080_1083delGACA|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001713507" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-06-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9554745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15712270</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16752392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16542389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17786384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22991266</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31630786</ID>
          </Citation>
          <Comment>PVS1, PS4, PP1_Strong, PM2, PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001114753.2:exon 8</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Thr361Serfs*7</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.2:c.1080_1083delGACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="538745" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2016-07-01">
        <ClinVarSubmissionID localKey="490773|MedGen:C0039445" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000283521" DateUpdated="2024-02-14" DateCreated="2016-07-01" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9554745</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16542389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17786384</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21158752</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22991266</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15879500</ID>
          </Citation>
          <Comment>This premature translational stop signal has been observed in individual(s) with hereditary hemorrhagic telangiectasia (PMID: 9554745, 16542389, 17786384, 21158752, 22991266). ClinVar contains an entry for this variant (Variation ID: 213214). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr361Serfs*7) in the ENG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130586634_130586637del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0039445" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB3109251</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4015817" SubmissionDate="2022-01-04" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="3061846|OMIM:187300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002050071" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories" OrgID="25969" OrganizationCategory="laboratory" OrgAbbreviation="ARUP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ENG c.1080_1083delGACA; p.Thr361SerfsTer7 variant (rs863223540), also reported as c.1078_1081del, is reported in the literature in multiple individuals affected with hereditary hemorrhagic telangiectasia (HHT) (Gallione 1998, Nishida 2012, Snellings 2019). This variant is also reported in ClinVar (Variation ID: 213214). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by deleting four nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Gallione CJ et al. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat. 1998;11(4):286-94. Nishida T et al. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. Am J Med Genet A. 2012 Nov;158A(11):2829-34. Snellings DA et al. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1. Am J Hum Genet. 2019 Nov 7;105(5):894-906.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ARUP Molecular Germline Variant Investigation Process 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ythvkvge/arup_molecular_germline_variant_investigation_process_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.130586636_130586639delTCTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="187300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>ARUP Molecular 2021</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8987111" SubmissionDate="2024-03-26" DateLastUpdated="2024-04-06" DateCreated="2024-04-06">
        <ClinVarSubmissionID localKey="NM_001114753.3:c.1080_1083del|OMIM:187300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004806757" DateUpdated="2024-04-06" DateCreated="2024-04-06" Type="SCV" Version="1" SubmitterName="Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center" OrgID="508075" OrganizationCategory="other" OrgAbbreviation="CGM_KFSHRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.3:c.1080_1083del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="187300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14340311</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5212292" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a50714|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002727072" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16542389</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21415079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9554745</ID>
          </Citation>
          <Comment>The c.1080_1083delGACA pathogenic mutation, located in coding exon 8 of the ENG gene, results from a deletion of 4 nucleotides at nucleotide positions 1080 to 1083, causing a translational frameshift with a predicted alternate stop codon (p.T361Sfs*7). This mutation has been identified in multiple individuals with epistaxis, telangiectasias, and pulmonary arteriovenous malformations (Gallione CJ et al. Hum. Mutat., 1998;11:286-94; Wehner LE et al. Clin. Genet., 2006 Mar;69:239-45; Lee NP et al. J. Med. Genet., 2011 May;48:353-7). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ENG" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001114753.1:c.1080_1083delGACA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="465174" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4015817" TraitType="Disease" MappingType="XRef" MappingValue="187300" MappingRef="OMIM">
        <MedGen CUI="C4551861" Name="Telangiectasia, hereditary hemorrhagic, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8987111" TraitType="Disease" MappingType="XRef" MappingValue="187300" MappingRef="OMIM">
        <MedGen CUI="C4551861" Name="Telangiectasia, hereditary hemorrhagic, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2842588" TraitType="Disease" MappingType="XRef" MappingValue="187300" MappingRef="OMIM">
        <MedGen CUI="C4551861" Name="Telangiectasia, hereditary hemorrhagic, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5212292" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3373940" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="538745" TraitType="Disease" MappingType="XRef" MappingValue="C0039445" MappingRef="MedGen">
        <MedGen CUI="C0039445" Name="Hereditary hemorrhagic telangiectasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

